Atlas Trials

NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial

Clinical trial NCT06783478 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06783478
Sponsor
Hospital de Clinicas de Porto Alegre
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukaemia (AML)
Start date
2025-04-01
Primary completion
2027-08-31
Enrollment
98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.